These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 30860449)

  • 1. Is Gadolinium-based Contrast Material Needed for MRI Follow-up of Multiple Sclerosis?
    Saindane AM
    Radiology; 2019 May; 291(2):436-437. PubMed ID: 30860449
    [No Abstract]   [Full Text] [Related]  

  • 2. Routine Gadolinium Use for MRI Follow-Up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.
    Rovira À; Auger C
    AJR Am J Roentgenol; 2022 Jul; 219(1):26-27. PubMed ID: 34786958
    [No Abstract]   [Full Text] [Related]  

  • 3. Serial gadolinium-enhanced magnetic resonance imaging in patients with multiple sclerosis treated with mitoxantrone.
    Krapf H; Mauch E; Fetzer U; Laufen H; Kornhuber HH
    Neuroradiology; 1995 Feb; 37(2):113-9. PubMed ID: 7760994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine Gadolinium Use for MRI Follow-Up of Multiple Sclerosis: Point-The Role of Leptomeningeal Enhancement.
    Okar SV; Reich DS
    AJR Am J Roentgenol; 2022 Jul; 219(1):24-25. PubMed ID: 34786959
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
    Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
    Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents.
    Gentili L; Capuano R; Gaetani L; Fiacca A; Bisecco A; d'Ambrosio A; Mancini A; Guercini G; Tedeschi G; Parnetti L; Gallo A; Di Filippo M
    J Neurol Sci; 2022 Nov; 442():120422. PubMed ID: 36162167
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging.
    Silver NC; Good CD; Barker GJ; MacManus DG; Thompson AJ; Moseley IF; McDonald WI; Miller DH
    Brain; 1997 Jul; 120 ( Pt 7)():1149-61. PubMed ID: 9236628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fat-saturated post gadolinium T1 imaging of the brain in multiple sclerosis.
    Al-Saeed O; Ismail M; Athyal R; Sheikh M
    Acta Radiol; 2011 Jun; 52(5):570-4. PubMed ID: 21498296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile.
    Lebrun C; Bensa C; Debouverie M; De Seze J; Wiertlievski S; Brochet B; Clavelou P; Brassat D; Labauge P; Roullet E;
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):195-8. PubMed ID: 18202208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.
    Rovira A; Swanton J; Tintoré M; Huerga E; Barkhof F; Filippi M; Frederiksen JL; Langkilde A; Miszkiel K; Polman C; Rovaris M; Sastre-Garriga J; Miller D; Montalban X
    Arch Neurol; 2009 May; 66(5):587-92. PubMed ID: 19433658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast enhanced magnetic resonance imaging of the brain using gadolinium-DTPA.
    Valk J; de Slegte RG; Crezee FC; Hazenberg GJ; Thjaha SI; Nauta JJ
    Acta Radiol; 1987; 28(6):659-65. PubMed ID: 2962597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contrast agents in MRI-diagnosis of multiple sclerosis].
    Abakumova TO; Nukolova NV; Gusev EI; Chekhonin VP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):58-65. PubMed ID: 25909791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Magnetic resonance imaging of disseminated sclerosis].
    Christiansen AP; Wanscher B; Larsson HB; Henriksen O
    Ugeskr Laeger; 1994 Oct; 156(43):6348-52. PubMed ID: 7810007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic impact of selective use of contrast for routine follow-up MRI of patients with multiple sclerosis.
    Mattay RR; Davtyan K; Rudie JD; Mattay GS; Jacobs DA; Schindler M; Loevner LA; Schnall MD; Bilello M; Mamourian AC; Cook TS
    J Neuroimaging; 2022 Jul; 32(4):656-666. PubMed ID: 35294074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Gadolinium-Phobia:" Not a Helpful "Criterion" for Indication for Gadolinium-based Contrast Agent Administration in Multiple Sclerosis.
    Goischke HK
    Radiology; 2016 Oct; 281(1):323-4. PubMed ID: 27643774
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.
    Splendiani A; Perri M; Marsecano C; Vellucci V; Michelini G; Barile A; Di Cesare E
    Radiol Med; 2018 Feb; 123(2):125-134. PubMed ID: 28952018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The characteristics of enhanced gadolinium DTPA brain magnetic resonance images in 298 multiple sclerosis patients].
    Zhang H; Xu XH; Zhao ZG; Guo H; Qiao LY; Yin J; Hou SF; Wei XF; Wen SG; Geng Y; Jiao YJ; Liu JH; Wang H
    Zhonghua Nei Ke Za Zhi; 2003 Jul; 42(7):490-1. PubMed ID: 12921611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis.
    Bastianello S; Pozzilli C; Bernardi S; Bozzao L; Fantozzi LM; Buttinelli C; Fieschi C
    Neurology; 1990 Apr; 40(4):591-5. PubMed ID: 2320230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.
    Raynaud JS; Darmon-Kern E; Lancelot E; Laurent AC; Desché P
    Radiol Med; 2018 Jun; 123(6):432-433. PubMed ID: 29476438
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine.
    Taschner CA; Kirsch EC; Scheffler K; Wetzel SG; Schulte-Mönting J; Kappos L; Radü EW
    Magn Reson Imaging; 2005 Apr; 23(3):469-74. PubMed ID: 15862648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.